Prednisolone
- Product NDC
- 52817-860
- Requested package NDC
- 52817-860-08
- 11-digit product format
- 528170860
- Labeler code
- 52817
- Product ID
- 52817-860_5a84db26-98d0-fe51-e063-6294a90a63ee
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Prednisolone oral
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- TRUPHARMA, LLC
- Application
- ANDA219509
- Marketing category
- ANDA
- Marketing start
- 2026-08-04
- Substance
- PREDNISOLONE
- Active strength
- 15 mg/5mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A219509-001 | PREDNISOLONE | PREDNISOLONE | 15MG/5ML | SOLUTION / ORAL | AA | 2025-06-23 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A219509-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219509-001 | PREDNISOLONE | 15MG/5ML | SOLUTION / ORAL | AA | 2025-06-23 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A219509-001 | PREDNISOLONE | 15MG/5ML | SOLUTION / ORAL | AA | 2025-06-23 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A219509-001 | PREDNISOLONE | 15MG/5ML | SOLUTION / ORAL | AA | 2025-06-23 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219509-001 | PREDNISOLONE | 15MG/5ML | SOLUTION / ORAL | AA | 2025-06-23 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A219509-001 | PREDNISOLONE | 15MG/5ML | SOLUTION / ORAL | AA | 2025-06-23 | 6a471c1ec25d… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219509-001 | PREDNISOLONE | 15MG/5ML | SOLUTION / ORAL | AA | 2025-06-23 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A219509-001 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A219509-001 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A219509-001 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A219509-001 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A219509-001 | AA | 1 | 6a471c1ec25d… |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A219509-001 | AA | 1 | a50c72e98297… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Prednisolone
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| PREDNISOLONE | 15 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 9PHQ9Y1OLM | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 283077 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4f83514d-5342-4748-a0d3-b0306ca303c8 | Available on FDA.report |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Prednisolone | PREDNISOLONE ORAL | TRUPHARMA, LLC | 4f83514d-5342-4748-a0d3-b0306ca303c8 | 2026-09-02 | Warnings, Adverse reactions | 219509 ANDA219509 52817-860-08 52817-860 52817086008 |
| Prednisolone | PREDNISOLONE ORAL | Tulex Pharmaceuticals Inc | 757b41c4-a0fe-4a09-8816-a4cdb7558f41 | 2026-07-08 | Warnings, Adverse reactions | 219509 ANDA219509 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 52817-860-08 | 52817086008 | 240 mL in 1 BOTTLE (52817-860-08) | 240 ml | 2026-08-04 | No | No | Current |